A compound probiotic preparation for regulating intestinal flora and its preparation method
By using a compound probiotic preparation method that divides material properties data and controls multiple parameters in real time, the problems of oxygen-sensitive strain inactivation and excipient clumping have been solved. This method achieves efficient protection of live bacteria and uniform mixing, ensuring product stability and intestinal regulation effects.
Patent Information
- Application Number
- CN202611576986.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-13
- Publication Date
- 2026-11-10
AI Technical Summary
In the existing preparation process of compound probiotic formulations, there are problems such as easy inactivation of oxygen-sensitive strains, moisture absorption and clumping of excipients, uneven distribution of live bacteria, poor batch stability, and rapid decline of live bacteria during shelf life.
Based on material property data, the material is divided into oxygen-sensitive probiotic phase, spore yeast phase, functional excipient phase, and carrier phase. The process employs phase-sequential feeding, fluidized bed atomization, and pulsed airflow stratified mixing, combined with real-time feedback control of multiple parameters, to achieve uniform mixing and precise packaging.
It improves the survival rate and mixing uniformity of live bacteria, reduces the attenuation of live bacteria during shelf life, ensures batch consistency of products and the effect of intestinal flora regulation, and is suitable for industrial production.
Smart Images

Figure CN123059092A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of probiotic preparation technology, specifically to a compound probiotic preparation that regulates intestinal flora and its preparation method. Background Technology
[0002] Compound probiotic preparations have gained attention in products related to gut microbiota regulation. These preparations often contain multiple live bacteria and functional excipients, such as *Lactobacillus casei*, *Bifidobacterium animalis*, *Bacillus subtilis*, *Saccharomyces boulardii*, *Pediococcus lactis*, as well as fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin. Different live bacteria differ in morphology, oxygen sensitivity, water activity adaptability, particle size distribution, and survival conditions. Different excipients also exhibit significant differences in particle size, flowability, hygroscopicity, and compatibility. Current preparation methods typically involve directly mixing the raw materials after weighing them according to the formula, or simply setting the feeding order and mixing time based on experience. This approach easily leads to oxygen-sensitive probiotics being exposed to excessive oxygen during feeding, mixing, and packaging, and also easily causes highly hygroscopic excipients to absorb moisture in the mixing chamber, resulting in powder sticking to the walls, clumping, localized increases in water activity, and uneven distribution of live bacteria.
[0003] When oxygen-sensitive bacteria such as *Lactobacillus casei* and *Bifidobacterium animalis* are present, changes in oxygen partial pressure during mixing directly affect the survival of viable bacteria. *Bacillus subtilis* and *Saccharomyces boulardii*, with their varying tolerances and morphologies, are prone to distribution fluctuations when added simultaneously with oxygen-sensitive bacteria and highly hygroscopic excipients due to differences in mixing intensity, local temperature, and moisture migration. Viable bacteria such as *Pediococcus lactis* also have specific requirements for the mixing environment. When fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silica, and maltodextrin are mixed together, differences in particle size can lead to stratification, differences in hygroscopicity can cause moisture redistribution between particles, and differences in compatibility can affect the local microenvironment. Without online monitoring of oxygen partial pressure, water activity, and viable bacteria distribution within the mixing chamber, operators cannot adjust the input rate and mixing intensity of each phase based on real-time conditions. Often, offline testing is only possible after mixing is complete, and by the time an anomaly is detected, the batch has already been finished, leaving limited room for adjustment. Summary of the Invention
[0004] The purpose of this invention is to provide a compound probiotic preparation for regulating intestinal flora and its preparation method, so as to solve the problems mentioned in the background art.
[0005] To achieve the above objectives, the present invention provides a compound probiotic preparation for regulating intestinal flora and a method for preparing the same, the method comprising: a. Ingredient preparation stage: Obtain material property data for Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, Pediococcus lactis, fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin. Based on the material property data, generate data to classify oxygen-sensitive probiotic phase, spore yeast phase, functional excipient phase, and carrier phase. b. Mixing stage: The process involves receiving the partitioning data, adding the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase, and the carrier phase into a mixing tank in the order determined by the partitioning data, collecting oxygen partial pressure data, water activity data, and viable bacteria distribution data in the mixing chamber during the addition process, and adjusting the addition speed and mixing intensity of each phase based on the oxygen partial pressure data, water activity data, and viable bacteria distribution data. c. Packaging stage: The system receives the live bacteria distribution data and water activity data output from the mixing stage, determines the dispensing cycle and headspace processing data based on the live bacteria distribution data and water activity data, and packages the product according to the dispensing cycle and headspace processing data.
[0006] Furthermore, in the ingredient preparation stage, obtaining material property data for Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, Pediococcus lactis, fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin includes: The viable count, water activity, particle size distribution, and oxygen sensitivity coefficient of the Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, and Pediococcus lactis were detected respectively to obtain probiotic attribute data. The particle size distribution, flowability, hygroscopicity, and compatibility of the oligofructose, glutamine, zinc oxide, chicken hydrolysate, silica, and maltodextrin were detected to obtain excipient property data. The probiotic attribute data and the excipient attribute data are input into a compatibility matrix. Based on the live bacteria survival risk value and moisture absorption risk value in the compatibility matrix, the division data of the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase and the carrier phase are generated, and the division data is transmitted to the mixing stage.
[0007] Furthermore, in the mixing stage, adding the oxygen-sensitive probiotic phase, the spore-forming yeast phase, the functional excipient phase, and the carrier phase into the mixing tank in a time sequence determined by the partitioning data includes: The first feeding sequence of the oxygen-sensitive probiotic phase and the spore-forming yeast phase is determined based on the live bacteria survival risk value in the segmentation data. The second feeding sequence of the functional auxiliary material phase and the carrier phase is determined based on the moisture absorption risk value in the segmentation data; First, a fluidized bed formed by the carrier phase is established in the mixing tank. Then, the oxygen-sensitive probiotic phase and the spore yeast phase are introduced into the fluidized bed in a pneumatic atomization manner according to the first feeding sequence. The functional excipient phase is introduced into the fluidized bed in a pulsed airflow manner according to the second feeding sequence to obtain the premixed material. The oxygen partial pressure data, water activity data, and viable bacteria distribution data of the premixed material are collected, and the oxygen partial pressure data, water activity data, and viable bacteria distribution data are fed back to the mixing intensity control terminal of the mixing tank.
[0008] Furthermore, the process involves first establishing a fluidized bed formed by the carrier phase within the mixing tank, then introducing the oxygen-sensitive probiotic phase and the spore-forming yeast phase into the fluidized bed via pneumatic atomization according to the first feeding sequence, and finally introducing the functional excipient phase into the fluidized bed via pulsed airflow according to the second feeding sequence, resulting in a premixed material comprising: The maltodextrin and silica in the carrier phase are fed into the mixing tank according to the ratio determined by the particle size distribution in the excipient property data, and the fluidized bed is formed by introducing dehumidified and deoxygenated gas. The droplet size of the aerodynamic atomization is set according to the oxygen sensitivity coefficient in the probiotic attribute data, so that the oxygen-sensitive probiotic phase and the spore yeast phase are attached to the surface of the carrier phase in the fluidized bed; Based on the hygroscopicity in the excipient property data, the pulse interval and airflow humidity of the pulsed airflow are set, so that the fructooligosaccharides, glutamine, zinc oxide and chicken hydrolysate in the functional excipient phase are deposited in batches on the surface of the carrier phase on which the oxygen-sensitive probiotic phase and the spore yeast phase are attached, to obtain the premixed material.
[0009] Furthermore, the pulse interval and humidity of the pulsed airflow are set according to the hygroscopicity in the excipient property data, so that the fructooligosaccharides, glutamine, zinc oxide, and chicken hydrolysate in the functional excipient phase are deposited in batches on the surface of the carrier phase attached with the oxygen-sensitive probiotic phase and the spore yeast phase, resulting in the premixed material comprising: The oligofructose and the maltodextrin were used as the first deposition batch, and the glutamine, the zinc oxide and the chicken hydrolysate were used as the second deposition batch. Based on the hygroscopicity in the auxiliary material property data, the deposition interval data between the first deposition batch and the second deposition batch is generated; According to the deposition interval data, the first deposition batch is first introduced into the fluidized bed, and the surface water content data of the material in the fluidized bed is collected; When the surface moisture content data reaches the deposition switching threshold determined by the hygroscopicity, the second deposition batch is introduced into the fluidized bed, and the silica is introduced into the fluidized bed in an airflow dispersion manner. The material temperature data and water activity data are collected after the second deposition batch is introduced, and the material temperature data and water activity data are transmitted to the mixing intensity control terminal.
[0010] Furthermore, the step of collecting material temperature data and water activity data after the introduction of the second deposition batch, and transmitting the material temperature data and water activity data to the mixing intensity control terminal includes: Temperature probes and water activity probes are installed at different axial positions in the mixing tank to collect the material temperature data and water activity data after the second sedimentation batch is introduced, respectively. The material temperature data, the water activity data, and the oxygen partial pressure data are aligned with the timestamps to generate a mixing process state matrix. Calculate the local overheating index and the local moisture absorption index based on the state matrix of the mixing process; The flow rate of the jacket cooling water in the mixing tank is adjusted according to the local overheat index, and the dew point of the gas treated for dehumidification and deoxygenation is adjusted according to the local moisture absorption index. The adjusted jacket cooling water flow rate and dew point data are then transmitted as feedback data to the mixing intensity control terminal.
[0011] Furthermore, in the packaging stage, receiving the viable bacteria distribution data and water activity data output from the mixing stage, determining the dispensing cycle time and headspace processing data based on the viable bacteria distribution data and water activity data, and packaging according to the dispensing cycle time and headspace processing data includes: The dispensing and metering accuracy is determined based on the uniformity of viable bacteria distribution in the viable bacteria distribution data, and the target headspace oxygen content of the packaging container is determined based on the water activity data. The dispensing and metering accuracy and the target headspace oxygen content data are sent to the dispensing machine and the headspace processing device. During the packaging process, data on the actual packaging quality and headspace oxygen content of each batch of material are collected. The actual dispensing quality and the headspace oxygen content data are compared with the dispensing measurement accuracy and the target headspace oxygen content data to generate packaging feedback data; The screw speed of the dispensing machine and the timing of vacuuming and nitrogen filling of the headspace treatment device are adjusted based on the packaging feedback data.
[0012] Furthermore, adjusting the screw speed of the dispensing machine and the vacuuming and nitrogen filling sequence of the headspace treatment device based on the packaging feedback data includes: Extract the actual packaging quality deviation and headspace oxygen content deviation from the packaging feedback data; The screw speed compensation data of the dispensing machine is generated based on the actual dispensing quality deviation; Based on the headspace oxygen content deviation, vacuum time compensation data and nitrogen filling time compensation data of the headspace treatment device are generated. The screw speed compensation data, the vacuuming time compensation data, and the nitrogen filling time compensation data are written into the control registers of the dispensing machine and the headspace processing device; The actual packaging quality and headspace oxygen content data of the next batch after the data is collected and written are then updated to update the packaging feedback data.
[0013] Furthermore, in the mixing stage, adjusting the input rate and mixing intensity of each phase based on the oxygen partial pressure data, the water activity data, and the viable bacteria distribution data includes: The oxygen partial pressure data, the water activity data, and the viable bacteria distribution data are input into the multivariate prediction controller; The multivariate predictive controller outputs the addition rate correction values for the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase, and the carrier phase; Calculate the mixing uniformity gradient based on the live bacteria distribution data; When the mixing uniformity gradient exceeds the uniformity control band determined by the live bacteria distribution data, the impeller speed and gas pulse frequency of the mixing tank are adjusted. The input speed correction value, the blade rotation speed, and the gas pulse frequency are synchronously written into the driver of the mixing tank, and the oxygen partial pressure data, water activity data, and viable bacteria distribution data after execution are collected as inputs for the next control cycle.
[0014] The present invention also includes a compound probiotic preparation for regulating intestinal flora, which is prepared by the above-mentioned method for preparing a compound probiotic preparation for regulating intestinal flora.
[0015] Compared with the prior art, the beneficial effects of the present invention are: The method provided in this application generates classification data for an oxygen-sensitive probiotic phase, a spore-forming yeast phase, a functional excipient phase, and a carrier phase based on material property data during the ingredient preparation stage. *Lactobacillus casei* and *Bifidobacterium animalis* are classified into the oxygen-sensitive probiotic phase; *Bacillus subtilis* and *Saccharomyces boulardii* are classified into the spore-forming yeast phase; fructooligosaccharides, glutamine, zinc oxide, and chicken hydrolysate are classified into the functional excipient phase; and silica and maltodextrin are classified into the carrier phase. This classification is based on data such as viable cell count, water activity, particle size distribution, oxygen sensitivity coefficient, flowability, hygroscopicity, and compatibility, allowing each phase to be processed separately under different conditions in subsequent processing. Compared to directly mixing all materials, oxygen-sensitive bacteria do not need to come into contact with highly hygroscopic excipients too early; the spore-forming yeast phase can be processed according to its own characteristics; and the functional excipient and carrier phases can be introduced in batches according to particle size and hygroscopicity, reducing the adverse effects caused by moisture migration and local concentration differences between materials.
[0016] In the mixing stage, the first feeding sequence of the oxygen-sensitive probiotic phase and the spore-forming yeast phase is determined based on the viable cell survival risk value, and the second feeding sequence of the functional excipient phase and the carrier phase is determined based on the hygroscopic risk value. A fluidized bed of the carrier phase is first established in the mixing tank, and then the oxygen-sensitive probiotic phase and the spore-forming yeast phase are introduced via pneumatic atomization, allowing the bacteria to adhere to the carrier surface and reducing powder dispersion and local agglomeration. The functional excipient phase is deposited in batches using a pulsed airflow method. Fructooligosaccharides and maltodextrin are used as the first deposition batch, and glutamine, zinc oxide, and chicken hydrolysate are used as the second deposition batch. The deposition interval is determined by hygroscopicity; the second deposition batch is introduced only after the surface moisture content reaches the deposition switching threshold. Simultaneously, silica is introduced via airflow dispersion to maintain a relatively loose dispersion state on the powder surface, reducing the tendency for agglomeration and wall adhesion. Oxygen partial pressure, water activity, and viable cell distribution are collected and input into a multivariate predictive controller, which outputs correction values for the input rate of each phase. The impeller speed and gas pulse frequency are adjusted according to the mixing uniformity gradient, so that the mixing intensity changes with the material state. Temperature probes and moisture activity probes are set at different positions along the axis. Oxygen partial pressure data are aligned according to timestamps to generate a mixing process state matrix. Local overheating index and local moisture absorption index are calculated. The flow rate of jacket cooling water and the dew point of dehumidifying and oxygen-removing gas are adjusted to reduce local temperature rise and local moisture accumulation. Attached Figure Description
[0017] Figure 1 This diagram illustrates the steps of preparing a compound probiotic preparation for regulating intestinal flora, as described in this invention. Detailed Implementation
[0018] The present invention will now be described in further detail with reference to specific embodiments. It should be understood that the specific embodiments described herein are for illustrative purposes only and are not intended to limit the scope of the invention.
[0019] This invention discloses a method for preparing a compound probiotic formulation that regulates intestinal flora. The core of this method is phase division based on the material properties of each raw material. Through a complete process involving phase-sequential feeding, fluidized bed atomization + pulsed airflow stratified mixing, real-time feedback control of mixing intensity using multiple parameters, and dispensing and headspace closed-loop controlled packaging, this method addresses industry pain points in traditional compound probiotic formulation preparations, such as inactivation of oxygen-sensitive strains, moisture absorption and clumping of excipients, uneven distribution of live bacteria, poor batch stability, and rapid decline in live bacteria over shelf life. All raw materials used in this invention are food-grade commercial raw materials, and the equipment used includes general-purpose closed mixing equipment, online detection equipment, and aseptic packaging equipment for probiotic formulation preparation. All operations are completed in a cleanroom with ambient temperature, sterility, and low humidity.
[0020] Example 1: See appendix Figure 1 A method for preparing a compound probiotic preparation for regulating intestinal flora includes an ingredient preparation stage, a mixing stage, and a packaging stage, with the specific steps as follows: a. Ingredient preparation stage Raw materials selected: Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, Pediococcus lactis, fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin. The viable count, water activity, particle size distribution, and oxygen sensitivity of each probiotic raw material were measured to obtain probiotic property data. The particle size distribution, flowability, hygroscopicity, and compatibility of each excipient raw material were measured to obtain excipient property data.
[0021] The probiotic attribute data and excipient attribute data are input into a preset compatibility matrix. Based on the viable bacteria survival risk value and hygroscopic risk value within the matrix, a four-phase division is completed: oxygen-sensitive probiotic phase (Lactobacillus casei, Bifidobacterium animalis, Pediococcus lactis), spore-forming yeast phase (Bacillus subtilis, Saccharomyces boulardii), functional excipient phase (fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate), and carrier phase (maltodextrin, silica). The four-phase division data is synchronously transmitted to the mixing stage control system.
[0022] The raw material ratio (parts by weight) in this embodiment is as follows: 2 parts Lactobacillus casei, 1.5 parts Bifidobacterium animalis, 1 part Pediococcus lactis, 2 parts Bacillus subtilis, 1.5 parts Saccharomyces boulardii, 8 parts fructooligosaccharides, 3 parts glutamine, 0.5 parts zinc oxide, 4 parts chicken hydrolysate, 2 parts silicon dioxide, and 74.5 parts maltodextrin.
[0023] b. Mixing stage The first feeding sequence is determined based on the survival risk value of live bacteria in the data: first add the spore yeast phase, then add the oxygen-sensitive probiotic phase; the second feeding sequence is determined based on the moisture absorption risk value: the functional auxiliary phase is deposited in two batches, with the carrier phase being added first to form the bed.
[0024] First, the carrier phases of maltodextrin and silica are added to a sealed mixing tank according to the particle size ratio. Nitrogen gas (dew point -40℃, oxygen content ≤0.3%) that has been dehumidified and deoxygenated is introduced into the tank to form a stable fluidized bed. Based on the oxygen sensitivity coefficient of the oxygen-sensitive probiotic phase, the aerodynamic atomization droplet size is set to 80μm. The spore-forming yeast phase and the oxygen-sensitive probiotic phase are then introduced into the fluidized bed sequentially and uniformly via aerodynamic atomization, ensuring that the bacterial strains are evenly attached to the surface of the carrier phase particles.
[0025] The functional excipients were divided into a first deposition batch (fructooligosaccharides and maltodextrin) and a second deposition batch (glutamine, zinc oxide, and chicken hydrolysate). Based on the hygroscopicity of the excipients, the pulse airflow interval was set to 15 seconds and the airflow humidity to 8%RH. The first deposition batch was first introduced into the fluidized bed in a pulse airflow manner, and the surface moisture content of the fluidized bed material was collected in real time. When the surface moisture content reached the deposition switching threshold of 0.8%, the second deposition batch was introduced. At the same time, silica was added by airflow dispersion to complete the material premixing.
[0026] Temperature probes, moisture activity probes, and oxygen partial pressure probes are installed at three positions along the mixing drum axis (upper, middle, and lower) to collect real-time data on material temperature, moisture activity, and intracavitary oxygen partial pressure. This data is then aligned with live bacteria distribution data by timestamp to generate a mixing process state matrix, and local overheating and hygroscopic indices are calculated. Real-time control is achieved using a multivariate predictive controller: jacket cooling water flow rate is controlled within a range of 5-15 L / min, dehumidification and deoxygenation gas dew point is controlled within a range of -35℃ to -45℃, and the mixing drum impeller speed is simultaneously adjusted to 300 r / min and the gas pulse frequency to 20 Hz. Live bacteria distribution, oxygen partial pressure, and moisture activity data are collected in real-time throughout the process, forming a closed-loop control system. The total mixing time is 25 minutes, yielding a uniform composite probiotic mixture.
[0027] c. Packaging stage The system receives data on the uniformity of viable bacteria distribution and the moisture activity of the material from the mixing stage. In this embodiment, the uniformity of viable bacteria distribution in the mixture is 96.8%, and the moisture activity is 0.28. Based on this data, the dispensing and metering accuracy is determined to be ±0.02g, and the target value for the headspace oxygen content of the packaging is set to ≤1.0%. The parameters are then simultaneously sent to the dispensing machine and the vacuum nitrogen-filled headspace treatment device.
[0028] During the packaging process, actual packaging quality and headspace oxygen content data are collected batch by batch and compared with target parameters to generate packaging feedback data. The screw speed of the packaging machine is compensated based on quality deviation, and the vacuuming and nitrogen filling sequence is compensated based on oxygen content deviation. Specifically, the vacuuming time is 8 seconds, the nitrogen filling time is 12 seconds, the packaging cycle is 30 bags / min, and aseptic sealing packaging is completed to obtain the finished compound probiotic preparation.
[0029] Example 2: A method for preparing a compound probiotic preparation that regulates intestinal flora is identical in overall process steps to that of Example 1, except for the adjustment of raw material ratios and matching process parameter gradients, as detailed below: The raw material ratio (parts by weight) in this embodiment is as follows: Lactobacillus casei 2.5 parts, Bifidobacterium animalis 2 parts, Pediococcus lactis 1.5 parts, Bacillus subtilis 1.5 parts, Saccharomyces boulardii 1 part, fructooligosaccharides 10 parts, glutamine 4 parts, zinc oxide 0.6 parts, chicken hydrolysate 5 parts, silicon dioxide 2.5 parts, and maltodextrin 69.4 parts.
[0030] Process parameters for the mixing stage are adjusted as follows: atomized droplet size of 90μm, pulse airflow interval of 12s, airflow humidity of 7%RH, deposition switching threshold of 0.7%, mixing tank impeller speed of 350r / min, gas pulse frequency of 25Hz, and total mixing time of 22min; the dehumidification and deoxygenation gas dew point is stably controlled at -42℃, and the jacket cooling water flow rate is 8-18L / min.
[0031] Packaging stage parameter adjustments: uniformity of live bacteria distribution in the mixture is 95.5%, water activity is 0.26, dispensing accuracy is ±0.02g, target value of headspace oxygen content is ≤0.8%, vacuuming time is 9s, nitrogen filling time is 14s, dispensing rate is 28 bags / min, and the remaining operations are the same as in Example 1.
[0032] Example 3: A method for preparing a compound probiotic preparation that regulates intestinal flora is identical in overall process steps to that of Example 1, except for the adjustment of raw material ratios and matching process parameter gradients, as detailed below: The raw material ratio (parts by weight) in this embodiment is as follows: Lactobacillus casei 1.5 parts, Bifidobacterium animalis 1 part, Pediococcus lactis 1 part, Bacillus subtilis 2.5 parts, Saccharomyces boulardii 2 parts, fructooligosaccharides 6 parts, glutamine 2 parts, zinc oxide 0.4 parts, chicken hydrolysate 3 parts, silicon dioxide 1.5 parts, and maltodextrin 78.1 parts.
[0033] Process parameters for the mixing stage are adjusted as follows: atomized droplet size of 70μm, pulse airflow interval of 18s, airflow humidity of 9%RH, deposition switching threshold of 0.9%, mixing tank impeller speed of 280r / min, gas pulse frequency of 18Hz, and total mixing time of 28min; the dehumidification and deoxygenation gas dew point is stably controlled at -38℃, and the jacket cooling water flow rate is 4-12L / min.
[0034] Packaging stage parameter adjustments: uniformity of live bacteria distribution in the mixture is 97.2%, water activity is 0.30, dispensing accuracy is ±0.03g, target value of headspace oxygen content is ≤1.2%, vacuuming time is 7s, nitrogen filling time is 10s, dispensing rate is 32 bags / min, and the remaining operations are the same as in Example 1.
[0035] Comparative Example 1: The traditional one-step mixing preparation process lacks phase separation, sequential feeding, and closed-loop parameter control. The specific steps are as follows: all raw materials of the same mass as in Example 1 are added to a sealed mixing tank at once and directly stirred at a constant speed of 400 r / min for 30 min. There is no dehumidification or deoxygenation gas control, no temperature or water activity feedback adjustment during the mixing process. After mixing, the raw materials are directly packaged using a conventional packaging machine without precise control of headspace oxygen content. Conventional vacuum nitrogen-filled packaging is used. The remaining raw materials and environmental conditions are completely consistent with those in Example 1.
[0036] Comparative Example 2: This method employs only simple phase-separation feeding, lacking precise stratified mixing and multi-parameter closed-loop control supported by material property data. Specifically, the raw materials are divided into probiotic, excipient, and carrier phases based on manual experience, without further subdivision into oxygen-sensitive and spore-forming yeast phases, and without establishing a compatibility matrix for risk assessment. The carrier phase is added directly in a single batch, followed by a general spraying of the probiotic and excipient phases. Mixing is performed using a fixed pulse frequency and fixed airflow humidity, without surface moisture content threshold switching, real-time feedback control of temperature and oxygen partial pressure, and a mixing time of 25 minutes. The packaging stage uses only a fixed dispensing cycle and fixed headspace parameters, without data closed-loop compensation. All other raw material ratios and environmental conditions are completely consistent with Example 1.
[0037] Comparative Example 3: The phase-sequential mixing process of this invention is adopted, but the linkage control of live bacteria distribution and water activity data is cancelled in the packaging stage. The specific steps are as follows: all process parameters and operation procedures in the ingredient preparation and mixing stages are completely consistent with those in Example 1. In the packaging stage, fixed dispensing and metering accuracy and fixed vacuuming and nitrogen filling sequence are adopted. No deviation compensation is performed based on the uniformity of live bacteria distribution and water activity data of each batch. There is no closed-loop control based on packaging feedback data. All other conditions are completely consistent with those in Example 1.
[0038] The finished compound probiotic preparations prepared in each example and comparative example were subjected to uniform testing. The testing indicators included: mixing uniformity, initial total viable count, water activity, and headspace oxygen content. The finished products were sealed and stored at 25°C and 60% relative humidity for 12 months. The viable bacteria survival rate at the end of the shelf life was tested, and the regulatory effect of the preparations on the intestinal flora of mice (Bifidobacterium proliferation rate and Escherichia coli inhibition rate) was also tested. All tests were conducted in triplicate, and the average value was taken as the final data.
[0039] Table 1: Comparison of core parameters for mixing and packaging of finished products in each embodiment and comparative example
[0040] As shown in Table 1, the core process parameters of the three sets of embodiments of the present invention are significantly better than those of the three sets of comparative examples, which fully verifies the superiority of the phase separation, time-sequential layered mixing, multi-parameter closed-loop control and packaging precision compensation processes of the present invention.
[0041] In Examples 1-3, the mixing uniformity was ≥95.5%, reaching a maximum of 97.2%, while the uniformity of the traditional one-step mixing method in Comparative Example 1 was only 82.3%, and in Comparative Example 2 without precise stratification control it was 88.6%, showing a significant difference. This is because the present invention achieves precise four-phase separation based on material properties. Through a stratified mixing mode involving carrier fluidized bed formation, probiotic atomized attachment, and batch pulse deposition of excipients, it avoids agglomeration and stratification phenomena that occur when materials with different properties are directly mixed. Simultaneously, multi-variable real-time control of the mixing intensity ensures the uniformity of material mixing. In contrast, traditional processes, lacking differentiated feeding and precise control, are prone to problems such as light materials floating, heavy materials settling, and excipient agglomeration, resulting in a significant reduction in mixing uniformity.
[0042] In the examples, the water activity of the finished product was stably controlled within the low hygroscopic range of 0.26-0.30, while the water activities of Comparative Examples 1 and 2 reached 0.45 and 0.37, respectively, significantly increasing the risk of moisture absorption. This invention effectively inhibits the moisture absorption and agglomeration of highly hygroscopic excipients such as fructooligosaccharides and glutamine by batch deposition of excipients, switching of surface moisture content thresholds, dynamic control of gas dew point, and closed-loop adjustment of local hygroscopic index, thus stably controlling the system's water activity within the range where probiotics are less likely to become inactive. In contrast, the comparative examples lacked dynamic hygroscopic control, resulting in continuous moisture absorption during the mixing process and exceeding the water activity limit.
[0043] In the examples, the headspace oxygen content was ≤1.15%, and the dispensing quality deviation was ≤±0.9%. In Comparative Example 1, the headspace oxygen content was as high as 3.85%, and the dispensing deviation was ±3.2%. In Comparative Example 3, due to the elimination of closed-loop packaging control, the headspace oxygen content and dispensing accuracy also showed significant deterioration. This demonstrates that the closed-loop packaging control process of this invention, based on the linkage of viable bacteria distribution and water activity data, can accurately match the packaging parameters of different batches of materials, effectively reduce residual oxygen in packaging, improve dispensing consistency, and solve the problems of large batch differences and excessively high residual oxygen caused by traditional fixed-parameter packaging.
[0044] Table 2: Comparison of viable bacteria performance of finished products from each example and comparative example
[0045] Table 2 provides a clear picture of the protective effect of the process of this invention on probiotics: In Examples 1-3, the initial total viable count was ≥2.5×10 CFU / g, significantly higher than 1.2×10 CFU / g in Comparative Example 1 and 1.8×10 CFU / g in Comparative Example 2, and essentially the same as Comparative Example 3, which had a similar process. The core reason is that this invention, through the time-differentiated feeding of the oxygen-sensitive phase and the spore-forming yeast phase, combined with continuous dehumidification and deoxygenation and real-time control of oxygen partial pressure, minimizes the risk of inactivation of oxygen-sensitive strains such as *Lactobacillus casei* and *Bifidobacterium animalis* during the mixing process due to exposure to a high-oxygen environment. In traditional one-step mixing processes, oxygen-sensitive strains are exposed to an oxygen-containing, high-humidity environment throughout, resulting in a large number of strain deaths and a significant reduction in the initial viable count. The mixing process in Comparative Example 3 was consistent with this invention, demonstrating excellent strain protection; therefore, the initial viable count was not significantly different from that of the Examples.
[0046] In the examples, the survival rate of oxygen-sensitive strains was ≥93.5%, compared to only 58.7% in Comparative Example 1 and 72.4% in Comparative Example 2, showing a highly significant difference. This invention, based on matching oxygen sensitivity coefficients with pneumatic atomization parameters, allows oxygen-sensitive strains to precisely attach to the surface of an inert carrier, where they are protected by an excipient layer. Simultaneously, it controls the oxygen partial pressure, temperature, and humidity within the cavity in real time, completely avoiding factors that induce inactivation of oxygen-sensitive strains. In contrast, traditional mixing processes lack targeted protection mechanisms, and oxygen-sensitive strains are subjected to multiple influences from oxygen, humidity, and localized high temperatures, resulting in significant losses.
[0047] In Example 1, the survival rate over the 12-month shelf life was ≥91.8%, demonstrating excellent stability. Comparative Example 1 showed a survival rate of only 65.3%, Comparative Example 2 76.5%, and Comparative Example 3 81.2%. This shows that precise control during the mixing stage ensures the initial viable bacterial count, while closed-loop headspace control during the packaging stage is crucial for maintaining long-term shelf stability. Comparative Example 3 met the mixing requirements, but lacked precise oxygen compensation in the packaging. The trace amounts of oxygen and moisture inside the packaging would continuously erode the bacterial strains, leading to accelerated viable bacterial decay during shelf life. This invention, through precise headspace control linking viable bacterial distribution and water activity, maintains extremely low levels of residual oxygen and moisture inside the packaging, maximizing the inhibition of bacterial inactivation during storage and significantly extending the product's shelf life.
[0048] Table 3: Comparison of the intestinal flora regulation efficacy of each embodiment and comparative example
[0049] The actual efficacy of the formulation can be verified through mouse intestinal flora repair experiments. The higher the flora proliferation rate, harmful bacteria inhibition rate, and repair score, the better the product's effect on regulating intestinal flora.
[0050] Examples 1-3 all showed a Bifidobacterium proliferation rate ≥40.5%, an Escherichia coli inhibition rate ≥36.8%, and a gut microbiota repair score ≥9.0, demonstrating excellent and stable overall efficacy. Among them, Example 2, due to its optimized probiotic ratio and highest live bacteria content, exhibited the best gut microbiota regulation effect, with a beneficial bacteria proliferation rate of 45.3% and a harmful bacteria inhibition rate of 40.2%.
[0051] Comparative Example 1 showed the worst efficacy in formulations prepared using traditional methods, with a beneficial bacteria proliferation rate of only 22.6%, a harmful bacteria inhibition rate of 18.3%, and a repair score of only 6.1. The core reason is that formulations prepared using traditional methods have low live bacteria counts, poor strain activity, and uneven material mixing. Furthermore, the functional excipients and probiotics cannot form a synergistic effect, thus failing to effectively exert their intestinal regulatory function.
[0052] Comparative Example 2 employed a simplified phase-separation mixing process, resulting in a slight improvement in efficacy, but still significantly lower than that of the embodiments of this invention. Due to the lack of precise layering protection supported by material property data, some probiotics were inactivated, and excipients agglomerated. The synergistic effect of probiotics, prebiotics, and functional excipients could not be fully realized, thus limiting efficacy.
[0053] Comparative Example 3 has a well-developed mixing process and retains probiotic activity well, thus its efficacy is superior to Comparative Examples 1 and 2. However, due to the lack of precise closed-loop control in the packaging, the activity of the strains decays rapidly during the shelf life, resulting in insufficient effective dosage. Compared with the examples, there is still a significant difference in efficacy, which fully demonstrates the decisive role of the closed-loop process of the present invention in the final efficacy of the product.
[0054] Table 4: Comparison of batch-to-batch stability of process parameters in various embodiments (range of 5 batches repeated tests)
[0055] In Examples 1-3 of this invention, the batch ranges of each detection index were all at extremely low levels: the range of mixing uniformity was ≤1.1%, the range of total viable bacteria count was ≤0.4×10 CFU / g, the range of water activity was ≤0.02%, and the range of headspace oxygen content was ≤0.18%. This proves that the whole-process technology of this invention, based on material property data modeling, multi-variable real-time closed-loop control, and dynamic compensation of packaging parameters, can be fully adapted to industrial continuous production, effectively avoiding product quality fluctuations caused by manual operation, equipment fluctuations, and material batch differences, and achieving excellent batch consistency.
[0056] In Comparative Example 1, the traditional process exhibited significantly larger ranges for all indicators, with a mixing uniformity range of 5.6%, a total viable bacteria count range as high as 1.8 × 10 CFU / g, and a headspace oxygen content range of 1.25%. The process stability was extremely poor, making stable industrial production impossible. This was due to the lack of any data-driven control and closed-loop compensation mechanisms; the production process relied entirely on fixed parameters, failing to adapt to even minor fluctuations in materials and equipment, resulting in significant differences in product quality between batches.
[0057] The batch stability of the simplified phase separation process in Comparative Example 2 is better than that in Comparative Example 1, but far worse than that in the Example. The main reason is the lack of precise parameter matching and multi-dimensional real-time feedback control supported by material property data. The process has weak anti-interference ability and obvious batch fluctuations.
[0058] Comparative Example 3 showed that the process stability during the mixing stage was similar to that of the Example, but there was no closed-loop compensation during the packaging stage. The batch-to-batch headspace oxygen content range was as high as 0.62%, and the shelf-life stability between batches varied significantly. This further demonstrates the necessity and advancement of the closed-loop control of the entire mixing and packaging process of this invention.
[0059] Compared to traditional one-step mixing and simplified phase separation processes, the compound probiotic preparation prepared by this invention possesses multiple advantages, including high viable bacteria content, stable strain activity, good mixing uniformity, excellent batch-to-batch consistency, long shelf life, and significant intestinal flora regulation effects. Furthermore, the process enables automated, data-driven, and standardized industrial production with strong anti-interference capabilities, demonstrating high industrial application value. Three sets of gradient examples verified that the process of this invention can stably produce high-quality products within a reasonable raw material ratio range, exhibiting wide process adaptability. Three sets of comparative examples respectively verified the indispensability of the three core processes: phase separation, closed-loop mixing control, and closed-loop packaging control, proving the inventiveness and novelty of the technical solution of this invention.
[0060] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.
Claims
1. A method for preparing a compound probiotic preparation for regulating intestinal flora, characterized in that, Includes the following steps: a. Ingredient preparation stage: Obtain material property data for Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, Pediococcus lactis, fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin. Based on the material property data, generate data to classify oxygen-sensitive probiotic phase, spore yeast phase, functional excipient phase, and carrier phase. b. Mixing stage: The process involves receiving the partitioning data, adding the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase, and the carrier phase into a mixing tank in the order determined by the partitioning data, collecting oxygen partial pressure data, water activity data, and viable bacteria distribution data in the mixing chamber during the addition process, and adjusting the addition speed and mixing intensity of each phase based on the oxygen partial pressure data, water activity data, and viable bacteria distribution data. c. Packaging stage: The system receives the live bacteria distribution data and water activity data output from the mixing stage, determines the dispensing cycle and headspace processing data based on the live bacteria distribution data and water activity data, and packages the product according to the dispensing cycle and headspace processing data.
2. The method for preparing a compound probiotic preparation for regulating intestinal flora according to claim 1, characterized in that, In the ingredient preparation stage, the material property data for obtaining Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, Pediococcus lactis, fructooligosaccharides, glutamine, zinc oxide, chicken hydrolysate, silicon dioxide, and maltodextrin include: The viable count, water activity, particle size distribution, and oxygen sensitivity coefficient of the Lactobacillus casei, Bifidobacterium animalis, Bacillus subtilis, Saccharomyces boulardii, and Pediococcus lactis were detected respectively to obtain probiotic attribute data. The particle size distribution, flowability, hygroscopicity, and compatibility of the oligofructose, glutamine, zinc oxide, chicken hydrolysate, silica, and maltodextrin were detected to obtain excipient property data. The probiotic attribute data and the excipient attribute data are input into a compatibility matrix. Based on the live bacteria survival risk value and moisture absorption risk value in the compatibility matrix, the division data of the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase and the carrier phase are generated, and the division data is transmitted to the mixing stage.
3. The method for preparing a compound probiotic preparation for regulating intestinal flora according to claim 2, characterized in that, In the mixing stage, the oxygen-sensitive probiotic phase, the spore-forming yeast phase, the functional excipient phase, and the carrier phase are added to the mixing tank in a time sequence determined by the partitioning data, including: The first feeding sequence of the oxygen-sensitive probiotic phase and the spore-forming yeast phase is determined based on the live bacteria survival risk value in the segmentation data. The second feeding sequence of the functional auxiliary material phase and the carrier phase is determined based on the moisture absorption risk value in the segmentation data; First, a fluidized bed formed by the carrier phase is established in the mixing tank. Then, the oxygen-sensitive probiotic phase and the spore yeast phase are introduced into the fluidized bed in a pneumatic atomization manner according to the first feeding sequence. The functional excipient phase is introduced into the fluidized bed in a pulsed airflow manner according to the second feeding sequence to obtain the premixed material. The oxygen partial pressure data, water activity data, and viable bacteria distribution data of the premixed material are collected, and the oxygen partial pressure data, water activity data, and viable bacteria distribution data are fed back to the mixing intensity control terminal of the mixing tank.
4. The preparation method of a compound probiotic preparation for regulating intestinal flora according to claim 3, characterized in that, The process involves first establishing a fluidized bed formed by the carrier phase within the mixing tank, then introducing the oxygen-sensitive probiotic phase and the spore-forming yeast phase into the fluidized bed via pneumatic atomization according to the first feeding sequence, and finally introducing the functional excipient phase into the fluidized bed via pulsed airflow according to the second feeding sequence, resulting in a premixed material comprising: The maltodextrin and silica in the carrier phase are fed into the mixing tank according to the ratio determined by the particle size distribution in the excipient property data, and the fluidized bed is formed by introducing dehumidified and deoxygenated gas. The droplet size of the aerodynamic atomization is set according to the oxygen sensitivity coefficient in the probiotic attribute data, so that the oxygen-sensitive probiotic phase and the spore yeast phase are attached to the surface of the carrier phase in the fluidized bed; Based on the hygroscopicity in the excipient property data, the pulse interval and airflow humidity of the pulsed airflow are set, so that the fructooligosaccharides, glutamine, zinc oxide and chicken hydrolysate in the functional excipient phase are deposited in batches on the surface of the carrier phase on which the oxygen-sensitive probiotic phase and the spore yeast phase are attached, to obtain the premixed material.
5. The preparation method of a compound probiotic preparation for regulating intestinal flora according to claim 4, characterized in that, The pulse interval and humidity of the pulsed airflow are set according to the hygroscopicity of the excipient properties data, so that the fructooligosaccharides, glutamine, zinc oxide and chicken hydrolysate in the functional excipient phase are deposited in batches on the surface of the carrier phase attached with the oxygen-sensitive probiotic phase and the spore yeast phase, to obtain the premixed material comprising: The oligofructose and the maltodextrin were used as the first deposition batch, and the glutamine, the zinc oxide and the chicken hydrolysate were used as the second deposition batch. Based on the hygroscopicity in the auxiliary material property data, the deposition interval data between the first deposition batch and the second deposition batch is generated; According to the deposition interval data, the first deposition batch is first introduced into the fluidized bed, and the surface water content data of the material in the fluidized bed is collected; When the surface moisture content data reaches the deposition switching threshold determined by the hygroscopicity, the second deposition batch is introduced into the fluidized bed, and the silica is introduced into the fluidized bed in an airflow dispersion manner. The material temperature data and water activity data are collected after the second deposition batch is introduced, and the material temperature data and water activity data are transmitted to the mixing intensity control terminal.
6. The method for preparing a compound probiotic preparation for regulating intestinal flora according to claim 5, characterized in that, The step of collecting material temperature data and water activity data after the introduction of the second deposition batch, and transmitting the material temperature data and water activity data to the mixing intensity control terminal includes: Temperature probes and water activity probes are installed at different axial positions in the mixing tank to collect the material temperature data and water activity data after the second sedimentation batch is introduced, respectively. The material temperature data, the water activity data, and the oxygen partial pressure data are aligned with the timestamps to generate a mixing process state matrix. Calculate the local overheating index and the local moisture absorption index based on the state matrix of the mixing process; The flow rate of the jacket cooling water in the mixing tank is adjusted according to the local overheat index, and the dew point of the gas treated for dehumidification and deoxygenation is adjusted according to the local moisture absorption index. The adjusted jacket cooling water flow rate and dew point data are then transmitted as feedback data to the mixing intensity control terminal.
7. The preparation method of a compound probiotic preparation for regulating intestinal flora according to claim 1, characterized in that, In the packaging stage, the viable bacteria distribution data and water activity data output from the mixing stage are received; based on the viable bacteria distribution data and water activity data, the dispensing cycle time and headspace processing data are determined; and packaging is performed according to the dispensing cycle time and headspace processing data, including: The dispensing and metering accuracy is determined based on the uniformity of viable bacteria distribution in the viable bacteria distribution data, and the target headspace oxygen content of the packaging container is determined based on the water activity data. The dispensing and metering accuracy and the target headspace oxygen content data are sent to the dispensing machine and the headspace processing device. During the packaging process, data on the actual packaging quality and headspace oxygen content of each batch of material are collected. The actual dispensing quality and the headspace oxygen content data are compared with the dispensing measurement accuracy and the target headspace oxygen content data to generate packaging feedback data; The screw speed of the dispensing machine and the timing of vacuuming and nitrogen filling of the headspace treatment device are adjusted based on the packaging feedback data.
8. The method for preparing a compound probiotic preparation for regulating intestinal flora according to claim 7, characterized in that, The adjustment of the screw speed of the dispensing machine and the vacuuming and nitrogen filling sequence of the headspace treatment device based on the packaging feedback data includes: Extract the actual packaging quality deviation and headspace oxygen content deviation from the packaging feedback data; The screw speed compensation data of the dispensing machine is generated based on the actual dispensing quality deviation; Based on the headspace oxygen content deviation, vacuum time compensation data and nitrogen filling time compensation data of the headspace treatment device are generated. The screw speed compensation data, the vacuuming time compensation data, and the nitrogen filling time compensation data are written into the control registers of the dispensing machine and the headspace processing device; The actual packaging quality and headspace oxygen content data of the next batch after the data is collected and written are then updated to update the packaging feedback data.
9. The method for preparing a compound probiotic preparation for regulating intestinal flora according to claim 1, characterized in that, In the mixing stage, adjusting the input rate and mixing intensity of each phase based on the oxygen partial pressure data, the water activity data, and the viable bacteria distribution data includes: The oxygen partial pressure data, the water activity data, and the viable bacteria distribution data are input into the multivariate prediction controller; The multivariate predictive controller outputs the addition rate correction values for the oxygen-sensitive probiotic phase, the spore yeast phase, the functional excipient phase, and the carrier phase; Calculate the mixing uniformity gradient based on the live bacteria distribution data; When the mixing uniformity gradient exceeds the uniformity control band determined by the live bacteria distribution data, the impeller speed and gas pulse frequency of the mixing tank are adjusted. The input speed correction value, the blade rotation speed, and the gas pulse frequency are synchronously written into the driver of the mixing tank, and the oxygen partial pressure data, water activity data, and viable bacteria distribution data after execution are collected as inputs for the next control cycle.
10. A compound probiotic preparation for regulating intestinal flora, characterized in that, The compound probiotic preparation for regulating intestinal flora is prepared by any one of claims 1 to 9.
